DENNER ALEXANDER J — SEC insider filings

SEC reporting owner CIK 1361754. 46 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 46 filings on record, filed 2020-10-23 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Iterum Therapeutics plc (ITRM)10% owner1—2 legs · 20,619,949 sh · $50,007,2842
IRONWOOD PHARMACEUTICALS INC (IRWD)Director338 legs · 2,350,000 sh · $22,832,2102 legs · 6,730,800 sh · $20,530,44832
Innoviva, Inc. (INVA)10% owner812 legs · 723,000 sh · $9,249,5983 legs · 1,618,295 sh · $28,395,442—
BIOGEN INC. (BIIB)Director2——2
Sarissa Capital Acquisition Corp. (SRSA)10% owner2——2

Insider filings — DENNER ALEXANDER J

FiledFormIssuerReported transactionsSource
2026-09-174IRONWOOD PHARMACEUTICALS INC (IRWD)Grant/award (A): 3,694 @ $0EDGAR
2026-06-174IRONWOOD PHARMACEUTICALS INC (IRWD)Grant/award (A): 4,065 @ $0 · Grant/award (A): 63,481 @ $0EDGAR
2026-03-174IRONWOOD PHARMACEUTICALS INC (IRWD)Grant/award (A): 4,451 @ $0 · Sale (S): 6,725,000 @ $3.05 · Sale (S): 5,800 @ $3.31EDGAR
2025-12-174IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 4,178 @ $0EDGAR
2025-09-174IRONWOOD PHARMACEUTICALS INC (IRWD)Grant/award (A): 11,718 @ $0EDGAR
2025-06-174IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 24,193 @ $0EDGAR
2025-06-124IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 45,000 @ $0EDGAR
2025-04-044IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 10,416 @ $0EDGAR
2025-03-174/AInnoviva, Inc. (INVA)
jointly with Sarissa Capital Management LP
Holdings only — no transactions reportedEDGAR
2025-03-064Innoviva, Inc. (INVA)
jointly with Sarissa Capital Management LP
Sale (S): 151,175 @ $17.63 · Sale (S): 270,374 @ $17.63 · Sale (S): 1,196,746 @ $17.52EDGAR
2024-12-184IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 4,249 @ $0EDGAR
2024-09-184IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 3,282 @ $0EDGAR
2024-06-214IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 24,311 @ $0EDGAR
2024-06-184IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 2,572 @ $0EDGAR
2024-03-194IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,662 @ $0EDGAR
2023-12-194IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,347 @ $0EDGAR
2023-09-194IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,798 @ $0EDGAR
2023-06-224IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 22,350 @ $0EDGAR
2023-06-204Innoviva, Inc. (INVA)
jointly with Sarissa Capital Management LP
Purchase (P): 62,000 @ $13.13EDGAR
2023-06-204IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,359 @ $0EDGAR
2023-06-074Innoviva, Inc. (INVA)
jointly with Sarissa Capital Management LP
Purchase (P): 7,000 @ $13.04 · Purchase (P): 8,000 @ $13.05EDGAR
2023-05-304Innoviva, Inc. (INVA)
jointly with Sarissa Capital Management LP
Purchase (P): 50,000 @ $13.09 · Purchase (P): 30,000 @ $13.12 · Purchase (P): 120,000 @ $13.01EDGAR
2023-05-194/AInnoviva, Inc. (INVA)
jointly with Sarissa Capital Management LP
Purchase (P): 50,000 @ $13.07 · Purchase (P): 10,000 @ $13.05 · Purchase (P): 36,000 @ $13.48EDGAR
2023-05-194Innoviva, Inc. (INVA)
jointly with Sarissa Capital Management LP
Purchase (P): 50,000 @ $13.07 · Purchase (P): 10,000 @ $13.05EDGAR
2023-05-154Innoviva, Inc. (INVA)
jointly with Sarissa Capital Management LP
Purchase (P): 290,000 @ $12.34EDGAR
2023-03-174IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,438 @ $0EDGAR
2022-12-194IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,244 @ $0EDGAR
2022-09-194IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,374 @ $0EDGAR
2022-06-174BIOGEN INC. (BIIB)Grant/award (A): 1,370 @ $0EDGAR
2022-06-174IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,222 @ $0EDGAR
2022-06-034IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 21,571 @ $0EDGAR
2022-03-174IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,152 @ $0EDGAR
2021-12-174IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,211 @ $0EDGAR
2021-09-174IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,137 @ $0EDGAR
2021-07-024BIOGEN INC. (BIIB)Grant/award (A): 775 @ $0EDGAR
2021-06-164IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,229 @ $0EDGAR
2021-06-044IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 22,766 @ $0EDGAR
2021-03-174IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Grant/award (A): 1,235 @ $0EDGAR
2021-03-104IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Purchase (P): 150,000 @ $10.30 · Purchase (P): 75,000 @ $10.54EDGAR
2021-03-054IRONWOOD PHARMACEUTICALS INC (IRWD)
jointly with Sarissa Capital Management LP
Purchase (P): 350,000 @ $10.02 · Purchase (P): 250,000 @ $10 · Purchase (P): 175,000 @ $10.01EDGAR
2021-03-024IRONWOOD PHARMACEUTICALS INC (IRWD)Purchase (P): 505,100 @ $9.20 · Purchase (P): 344,900 @ $9.60 · Purchase (P): 500,000 @ $9.56EDGAR
2021-02-124Iterum Therapeutics plc (ITRM)
jointly with Sarissa Capital Management LP, Sarissa Capital Offshore Master Fund LP, Sarissa Capital Catapult Fund LLC, Sarissa Capital Hawkeye Fund LP, Sarissa Capital Master Fund II LP
Conversion (C): 20,619,949 · Sale (S): 10,000,000 @ $2.59 · Sale (S): 10,619,949 @ $2.27 · Conversion (C): 15,000,000 (derivative)EDGAR
2020-12-174IRONWOOD PHARMACEUTICALS INC (IRWD)Grant/award (A): 661 @ $0EDGAR
2020-11-094IRONWOOD PHARMACEUTICALS INC (IRWD)Grant/award (A): 12,258 @ $0 · Grant/award (A): 24,925 @ $0EDGAR
2020-11-034Sarissa Capital Acquisition Corp. (SRSA)
jointly with Sarissa Capital Acquisition Sponsor LLC, Sarissa Capital Management LP, Sarissa Capital Management GP LLC
Other (J): 31,250 (derivative) @ $0EDGAR
2020-10-234Sarissa Capital Acquisition Corp. (SRSA)
jointly with Sarissa Capital Acquisition Sponsor LLC, Sarissa Capital Management LP, Sarissa Capital Management GP LLC
Purchase (P): 3,333,333 (derivative) @ $1.50EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-22 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1361754 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs